Targeting astrocytes cells slows progression in Lou Gehrigs disease
February 4th, 2008 - 1:43 pm ICT by admin - Send to a friend:
London, Feb 4 (ANI): Researchers at University of California, San Diego (UCSD) School of Medicine have found that by targeting neuronal support cells called astrocytes can slow the progression of Amyotrophic lateral sclerosis (ALS), or Lou Gehrigs disease.
ALS is a progressive disease that attacks the motor neurons, long and complex nerve cells that reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the body and leads to loss of muscle control, paralysis and untimely death.
The study led by Don Cleveland, Ph.D., UCSD Professor of Medicine, Neurosciences and Cellular and Molecular Medicine revealed that small immune cells called microglia are damaged by mutations in the SOD1 protein in initial stages of ALS that leads to the degeneration of the motor neurons and something similar happens to astrocytes support cells, essential to neuronal function.
Mutant genes that cause ALS are expressed widely, not just in the motor neurons, Nature Neuroscience, quoted Cleveland, as saying.
Targeting the partner cells like astrocytes, which live in a synergistic environment with the neuron cells, helps stop the cascade of damage. Therapeutically, this is the big news, he added.
The study was conducted using a mice model where the researchers removed the mutant SOD1 gene in astrocytes.
The findings revealed that the reduction of the mutant SOD1 in astrocytes did not slow disease onset or early disease; however, the late stage of the disease was extended, nearly doubling the normal life expectancy of a mouse with ALS.
We tested what would happen if we removed the mutant gene from astrocytes in mouse models. What happened was it doubled the lifespan of the mouse after the onset of ALS, said Cleveland
Silencing the mutant gene in the astrocytes not only helps protect the motor neuron, but delays activation of mutant microglia that act to accelerate the progression of ALS, he added.
Researchers believe that the findings would help in developing new treatments to slow disease progression.
The findings appear in Nature Neuroscience. (ANI)
Related Stories
- Umbilical cord blood cell transplants may harbour Lou Gehrig’s cure - June 25, 2008
- Leaky blood vessels may play key role in Lou Gehrig’s progression - April 8, 2008
- Cancer gene helps in early brain development: Study - November 14, 2007
- Two separate studies link Huntington’’s disease to overactive immune response in the brain - July 15, 2008
- Genetic mechanism behind neurodegeneration in Huntingtons disease identified - January 10, 2008
- Researchers identify mechanism for nerve cell repair - June 4, 2008
- Swamping bad cells with good slows spinal cord disease - October 20, 2008
- New brain cells linked to cannabinoid signalling machinery - March 27, 2008
- Scientists shed light on genetics of Lou Gehrig’s disease progression - June 2, 2008
- Awakening dormant brain stem cells is possible, say scientists - June 7, 2008
- Cloning treats Parkinson’s disease in mice - March 24, 2008
- New methods identify, manipulate ”newborn” cells in Parkinsons patients - September 4, 2008
- Outnumbering bad cells with good reduces neuron loss, extends life in ALS rats - October 20, 2008
- Human protein may dramatically increase lifespan in Lou Gehrigs patients - November 28, 2007
- Dopamine ‘mother cells’ linked to Parkinson’s disease identified - April 8, 2008
- amyotrophic lateral sclerosis als
- california san diego
- disease onset
- don cleveland
- immune cells
- london feb
- lou gehrigs disease
- molecular medicine
- motor neuron
- motor neurons
- mouse models
- mutant gene
- mutant genes
- nerve cells
- neuronal function
- sod1 gene
- support cells
- synergistic environment
- ucsd school
- university of california san diego
Posted in Health Science, |

